ESTIMATED
05/16/2024
05/16/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.11 | -$0.11 | -$0.11 |
Q2 2024 | 3 | -$0.13 | -$0.11 | -$0.12 |
Q3 2024 | 1 | -$0.12 | -$0.12 | -$0.12 |
Q4 2024 | 1 | -$0.12 | -$0.12 | -$0.12 |
Q1 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
Q2 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
Q3 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
Q4 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
AIM ImmunoTech Inc. last posted its earnings results on Thursday, May 16th, 2024. The company reported $-0.12 earnings per share for the quarter, missing analysts' consensus estimates of $-0.11 by $0.01. The company had revenue of 40,000 for the quarter and had revenue of 202,000 for the year. AIM ImmunoTech Inc. has generated $-1 earnings per share over the last year ($-0.6 diluted earnings per share) and currently has a price-to-earnings ratio of -0.6. AIM ImmunoTech Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/15/2024 | Q1 2024 | -$0.12 | $40,000 | $40,000 | 03/29/2024 | Q4 2023 | -$0.26 | $36,500 | $65,000 | 11/14/2023 | Q3 2023 | -$0.15 | -$0.16 | -0.01 | $46,000 | 08/14/2023 | Q2 2023 | -$0.10 | $42,000 | 05/12/2023 | Q1 2023 | -$0.06 | $49,000 | 03/31/2023 | Q4 2022 | -$0.09 | $183,667 | $56,000 | 11/14/2022 | Q3 2022 | -$0.13 | $21,000 | 08/15/2022 | Q2 2022 | -$0.07 | -$0.10 | -0.03 | $30,000 | 05/13/2022 | Q1 2022 | -$0.09 | $33,000 | 03/31/2022 | Q4 2021 | -$0.08 | -$0.12 | -0.04 | $36,667 | $50,000 | 11/15/2021 | Q3 2021 | -$0.08 | $38,333 | $33,000 | 08/16/2021 | Q2 2021 | -$0.12 | $349,333 | $23,000 | 05/17/2021 | Q1 2021 | -$0.08 | $28,000 | 03/30/2021 | Q4 2020 | -$0.07 | -$0.09 | -0.02 | $353,667 | $42,000 | 11/12/2020 | Q3 2020 | -$0.09 | $360,000 | $36,000 | 08/14/2020 | Q2 2020 | -$0.10 | -$0.11 | -0.01 | $51,000 | $40,000 | 05/13/2020 | Q1 2020 | -$0.22 | $45,000 | 03/30/2020 | Q4 2019 | -$0.37 | -$0.07 | 0.3 | $150,667 | $50,000 | 11/14/2019 | Q3 2019 | -$0.97 | -$1.13 | -0.16 | $73,500 | $61,000 | 08/14/2019 | Q2 2019 | -$1.70 | -$1.07 | 0.63 | $64,000 | $29,000 |
---|
A. AIM ImmunoTech Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates.
A. The conference call for AIM ImmunoTech Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for AIM ImmunoTech Inc.'s latest earnings report can be read online.
A. AIM ImmunoTech Inc. (AMEX:AIM) has a recorded annual revenue of $202,000.
A. AIM ImmunoTech Inc. (AMEX:AIM) has a recorded net income of $202,000. AIM ImmunoTech Inc. has generated $-0.6 earnings per share over the last four quarters.
A. AIM ImmunoTech Inc. (AMEX:AIM) has a price-to-earnings ratio of -0.6 and price/earnings-to-growth ratio is -0.05.